Alector to host virtual R&D event on ABC platform and neurodegeneration pipeline

ALEC•2026-10-07

Alector will host a virtual R&D event on Oct. 13, 2026, at 8:00 a.m. PT, focused on its Alector Brain Carrier blood-brain barrier platform and updates on AL137, AL164, AL062 and ADP065.

1. Event details

Alector will host a virtual R&D event on Oct. 13, 2026, at 8:00 a.m. PT. The event will focus on its wholly owned Alector Brain Carrier blood-brain barrier platform, with program updates on AL137, AL164 and AL062 and additional discussion of ADP065.

Alector to host virtual R&D event on ABC platform and neurodegeneration pipeline

1. Event details

Related News

CN Energy Group director Jian Chen files initial beneficial ownership statement

IQVIA launches life science models to help predict clinical trial outcomes

Levi Strauss sees FY 2026 adjusted EPS of $1.54 to $1.56, versus $1.54 estimate

Levi Strauss raises FY margin and EPS outlook after strong Q3, plans $100 million buyback

Wolfspeed jumps on up to $1.5 billion conditional loan commitment from US